Camille J. Devereux

SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control

Magdalene K. Montgomery, Jacqueline Bayliss, Camille J. Devereux et al. · Science Translational Medicine · 2020 · 63 citations

Life Sciences, Endocrinology, Molecular Biology +17

Proximity proteomics reveals a mechanism of fatty acid transfer at lipid droplet-mitochondria- endoplasmic reticulum contact sites

Ayenachew Bezawork‐Geleta, Camille J. Devereux, Stacey N. Keenan et al. · Nature Communications · 2025 · 42 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies

Hamzeh Karimkhanloo, Stacey N. Keenan, Jacqueline Bayliss et al. · Scientific Reports · 2023 · 30 citations · Full text

Medicine, Pharmacology, Inflammation +16

Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice

Camille J. Devereux, Jacqueline Bayliss, Stacey N. Keenan et al. · American Journal of Physiology-Endocrinology and Metabolism · 2023 · 12 citations

Life Sciences, Biochemistry, Pharmacology +17

Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism

Marziyeh Anari, Hamzeh Karimkhanloo, Shuai Nie et al. · Cell Reports · 2024 · 11 citations · Full text

Life Sciences, Biochemistry, Pathology +17